Price movement over the last 24 hours
Alkindo Naratama Tbk vs UBC Medical Indonesia Tbk. — how do they compare? Alkindo Naratama Tbk trades at Rp690 (market cap 1.89T, 1.7K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp152 (market cap 556.95B, 60.83M 24h volume). The key difference: Alkindo Naratama Tbk is far larger — about 3.4× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (60.83M versus 1.7K). Which is the better fit depends on your goals.
| ALDO | LABS | |
|---|---|---|
Market Cap | 1.89T | 556.95B |
Volume | 1.7K | 60.83M |
Lot | 17 | 608.34K |
Turnover | 1.17M | 10.26B |
Average Price | 688.24 | 168.64 |
Value | 1.17M | 10.26B |
Indicative Equilibrium Price | 690 | 152 |
Indicative Equilibrium Volume | 1 | 4.52K |
Trailing returns across standard periods
Latest headlines on both assets
PT Alkindo Naratama Tbk (the "Company") was established based on Notarial Deed No 74 of Kikit Warianti SH, dated January 31, 1989. The Company's Articles of Association have been amended several times. The latest amendment was based on Notarial Deed No. 5 of Nunuy Rahmayati SH dated March 15, 2011 pertaining of Authorized share and paid-up capital, issuance of new share to be offered to the public in the Initial Public Offering, and amendment of the Article of Association of the Company to become a public entity
Read more on ALDO →PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →